BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37612006)

  • 1. Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients.
    Couto-Mallón D; Almenar-Bonet L; Barge-Caballero E; Hernández-Pérez FJ; López-Azor García JC; Valero-Masa MJ; Castel-Lavilla MÁ; Mirabet-Pérez S; Garrido-Bravo IP; Díez-López C; López-Granados A; Manrique-Antón R; Fernández-Pombo CN; Muñiz J; Crespo-Leiro MG
    J Am Coll Cardiol; 2023 Aug; 82(9):753-767. PubMed ID: 37612006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant coronary artery disease in children. A multicenter national survey.
    Pahl E; Zales VR; Fricker FJ; Addonizio LJ
    Circulation; 1994 Nov; 90(5 Pt 2):II56-60. PubMed ID: 7955283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of different gadolinium enhancement patterns in patients after heart transplantation.
    Steen H; Merten C; Refle S; Klingenberg R; Dengler T; Giannitsis E; Katus HA
    J Am Coll Cardiol; 2008 Sep; 52(14):1160-7. PubMed ID: 18804744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of percutaneous coronary intervention in transplant coronary artery disease in pediatric heart transplant recipients.
    Lee MS; Sachdeva R; Kim MH; Sachdeva R
    J Invasive Cardiol; 2012 Jun; 24(6):278-81. PubMed ID: 22684382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for transplant coronary artery disease in infant, child and adolescent heart transplant recipients: an intravascular ultrasound study.
    Nicolas RT; Kort HW; Balzer DT; Trinkaus K; Dent CL; Hirsch R; Canter CE
    J Heart Lung Transplant; 2006 Aug; 25(8):921-7. PubMed ID: 16890112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom complex is associated with transplant coronary artery disease and sudden death/resuscitated sudden death in pediatric heart transplant recipients.
    Price JF; Towbin JA; Dreyer WJ; Radovancevic B; Rosenblatt HM; Clunie SK; Denfield SW
    J Heart Lung Transplant; 2005 Nov; 24(11):1798-803. PubMed ID: 16297785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study.
    Pahl E; Naftel DC; Kuhn MA; Shaddy RE; Morrow WR; Canter CE; Kirklin J;
    J Heart Lung Transplant; 2005 Jun; 24(6):645-51. PubMed ID: 15949722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of soluble adhesion molecules and plasma coagulation markers in assessing transplant coronary artery disease in pediatric heart transplant recipients.
    Hilgendorff A; Kraemer U; Afsharian M; Bauer J; Tillmanns H; Kemkes-Matthes B; Kreuder J; Hoelschermann H
    Pediatr Transplant; 2006 Jun; 10(4):434-40. PubMed ID: 16712600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.
    Lee MS; Cheng RK; Kandzari DE; Kirtane AJ
    Am J Cardiol; 2012 Jun; 109(12):1729-32. PubMed ID: 22465319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of donor-transmitted coronary artery disease and its influence on heart transplant outcomes.
    Estevez-Loureiro R; Paniagua-Martin MJ; Calviño-Santos R; Vazquez-Rodríguez JM; Salgado-Fernandez J; Marzoa-Rivas R; Barge-Caballero E; Grille Z; Pérez-Pérez A; Rodríguez-Fernandez JA; Vázquez-González N; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
    Transplant Proc; 2010 Oct; 42(8):2987-91. PubMed ID: 20970589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-transmitted coronary atherosclerosis.
    Grauhan O; Patzurek J; Hummel M; Lehmkuhl H; Dandel M; Pasic M; Weng Y; Hetzer R
    J Heart Lung Transplant; 2003 May; 22(5):568-73. PubMed ID: 12742420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients.
    Li H; Tanaka K; Anzai H; Oeser B; Lai D; Kobashigawa JA; Tobis JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2470-6. PubMed ID: 16781375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease.
    Yousufuddin M; Cook DJ; Starling RC; Abdo A; Paul P; Tuzcu EM; Ratliff NB; McCarthy PM; Young JB; Yamani MH
    J Am Coll Cardiol; 2004 May; 43(9):1565-73. PubMed ID: 15120813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of donor age on transplant coronary artery disease and survival post heart transplantation: is it safe to extend donor age?
    Walker AH; Fildes JE; Leonard CT; Yonan N
    Transplant Proc; 2004 Dec; 36(10):3139-41. PubMed ID: 15686713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures.
    Jutte NH; Groeneveld K; Balk AH; Ouwehand AJ; Loonen EH; Van der Linden M; Strikwerda S; Mochtar B; Claas FH; Weimar W
    Clin Exp Immunol; 1994 Oct; 98(1):158-62. PubMed ID: 7923876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
    Lietz K; John R; Mancini DM; Edwards NM
    J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease.
    Lee MS; Yang T; Kandzari D; Mahmud E; Liao H; Kirtane A
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):533-8. PubMed ID: 21953766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant coronary artery disease.
    Zimmer RJ; Lee MS
    JACC Cardiovasc Interv; 2010 Apr; 3(4):367-77. PubMed ID: 20398862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.
    Sperry BW; Qarajeh R; Omer MA; Brandt H; Safley D; Borkon AM; Everley MP; Fendler TJ; Khumri TM; Lawhorn SL; Magalski A; Nassif ME; Vodnala D; Kao AC; Austin BA
    J Card Fail; 2021 Apr; 27(4):464-472. PubMed ID: 33358960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of fractional flow reserve derived from coronary computed tomographic angiography and plaque quantitative analysis in predicting adverse outcomes of non-obstructive coronary heart disease].
    Liu J; Wu Y; Huang H; Wang P; Wu Q; Qiao H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):615-619. PubMed ID: 37366128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.